scholarly article | Q13442814 |
P2093 | author name string | Takeuchi S | |
Cho SK | |||
Koeffler HP | |||
Cesarman E | |||
Knowles DM | |||
de Vos S | |||
Asou H | |||
Chien K | |||
Said W | |||
Tasaka T | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | primary effusion lymphoma | Q3832899 |
P304 | page(s) | 4937-4943 | |
P577 | publication date | 1996-06-01 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells | |
P478 | volume | 87 |
Q40015547 | A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus |
Q38628596 | An Unusual Case of Invasive Kaposi's Sarcoma with Primary Effusion Lymphoma in an HIV Positive Patient: Case Report and Literature Review. |
Q36180568 | An unusual case of Primary Effusion Lymphoma with aberrant T-cell phenotype in a HIV-negative, HBV-positive, cirrhotic patient, and review of the literature |
Q33999509 | Anti-CD20 monoclonal antibody treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virus-negative patient |
Q35943718 | Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression. |
Q33717233 | Development of the human cancer microRNA network |
Q35131811 | Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma |
Q35787282 | High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma |
Q24683663 | Human herpesvirus 6 |
Q35697724 | Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73. |
Q40002946 | Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. |
Q30840864 | Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus |
Q33784194 | Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene |
Q31977172 | Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation |
Q35758675 | K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus. |
Q34186465 | Kaposi's sarcoma-associated herpesvirus (KSHV): a new viral pathogen associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease |
Q24555724 | Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells |
Q33653424 | Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression |
Q44152306 | Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions |
Q35026060 | Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis |
Q40335673 | NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo |
Q35179783 | Pathology of Kaposi’s sarcoma-associated herpesvirus infection |
Q39581248 | Persistent Infection of Epstein-Barr Virus-Positive B Lymphocytes by Human Herpesvirus 8 |
Q35770402 | Primary effusion lymphoma with skin involvement |
Q31121774 | Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes |
Q33906970 | Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases |
Q73497825 | Summary of the II international consensus symposium on combined antiviral therapy and implications for future therapies |
Q40426206 | The Itch ubiquitin ligase is required for KSHV RTA induced vFLIP degradation |
Q35077558 | The Single RBP-Jκ Site within the LANA Promoter Is Crucial for Establishing Kaposi's Sarcoma-Associated Herpesvirus Latency during Primary Infection |
Q39764530 | The phosphatase Shp2 is required for signaling by the Kaposi's sarcoma-associated herpesvirus viral GPCR in primary endothelial cells |
Q39590310 | The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577 |
Q34069105 | Transcription Mapping of the Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Genome in a Body Cavity-Based Lymphoma Cell Line (BC-1) |
Q35000927 | Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). |
Q37088015 | Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines |
Q37251335 | Use of virion DNA as a cloning vector for the construction of mutant and recombinant herpesviruses |
Search more.